Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Summary Of Significant Accounting Policies [Line Items] | ||||
| Segment research and development | $ (2,102) | $ (4,052) | $ (5,587) | $ (8,276) |
| Segment general and administrative | (1,910) | (2,569) | (4,036) | (4,842) |
| Consolidated operating loss | (4,012) | (6,621) | (9,623) | (13,118) |
| Operating Segments [Member] | ||||
| Summary Of Significant Accounting Policies [Line Items] | ||||
| Segment research and development | (1,874) | (3,664) | (5,135) | (7,704) |
| Segment general and administrative | (1,591) | (1,769) | (3,373) | (3,661) |
| Stock-based compensation | (540) | (1,174) | (1,101) | (1,724) |
| Depreciation expense | (7) | (14) | (14) | (29) |
| Consolidated operating loss | $ (4,012) | $ (6,621) | $ (9,623) | $ (13,118) |
| X | ||||||||||
- Definition Summary of significant accounting policies. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|